{"id":2874,"date":"2023-02-07T02:17:25","date_gmt":"2023-02-07T02:17:25","guid":{"rendered":"https:\/\/aisperu.org.pe\/?p=2874"},"modified":"2025-04-14T17:27:55","modified_gmt":"2025-04-14T17:27:55","slug":"nuevo-efecto-adverso-de-la-vacuna-de-astrazeneca","status":"publish","type":"post","link":"https:\/\/aisperu.org.pe\/cms\/nuevo-efecto-adverso-de-la-vacuna-de-astrazeneca\/","title":{"rendered":"<strong>NUEVO EFECTO ADVERSO DE LA VACUNA DE ASTRAZENECA<\/strong>"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">El 26 de enero el diario AS<a id=\"_ftnref1\" href=\"#_ftn1\">[1]<\/a> de Espa\u00f1a dio a conocer que la\u00a0Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS), ha publicado su\u00a0<a href=\"https:\/\/www.aemps.gob.es\/laAEMPS\/docs\/informe-farmacovigilancia-diciembre-2022.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">19\u00aa informe de farmacovigilancia<\/a>\u00a0en el que se actualiza la informaci\u00f3n de seguridad sobre las\u00a0vacunas de la COVID-19\u00a0y sus posibles reacciones adversas.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">En dicha actualizaci\u00f3n se informa sobre el descubrimiento de una nueva reacci\u00f3n adversa de la vacuna contra la COVID-19 de AstraZeneca. De acuerdo al informe del Ministerio de Sanidad, existen posibilidades de desarrollar vasculitis cut\u00e1nea.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">En el informe se ha tenido en cuenta evaluaciones de casos \u201cque se diagnostican en los\u00a0programas de notificaci\u00f3n de efectos secundarios\u00a0tras la vacunaci\u00f3n.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Seg\u00fan detalla el informe del Ministerio de Sanidad<a id=\"_ftnref2\" href=\"#_ftn2\">[2]<\/a>, la vasculitis cut\u00e1nea es \u201cuna inflamaci\u00f3n de los vasos sangu\u00edneos de la piel, manifestada frecuentemente en forma de erupci\u00f3n cut\u00e1nea o como peque\u00f1as manchas rojas o viol\u00e1ceas, planas y redondas, bajo la superficie de la piel, o cardenales.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"#_ftnref1\" id=\"_ftn1\">[1]<\/a> <a href=\"https:\/\/as.com\/actualidad\/revelan-un-nuevo-efecto-secundario-de-la-vacuna-covid-de-astrazeneca-n\/\">https:\/\/as.com\/actualidad\/revelan-un-nuevo-efecto-secundario-de-la-vacuna-covid-de-astrazeneca-n\/<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"#_ftnref2\" id=\"_ftn2\">[2]<\/a> <a href=\"https:\/\/www.aemps.gob.es\/laAEMPS\/docs\/informe-farmacovigilancia-diciembre-2022.pdf\">https:\/\/www.aemps.gob.es\/laAEMPS\/docs\/informe-farmacovigilancia-diciembre-2022.pdf<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>El 26 de enero el diario AS[1] de Espa\u00f1a dio a conocer que la\u00a0Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS), ha publicado su\u00a019\u00aa informe de farmacovigilancia\u00a0en el que se actualiza la informaci\u00f3n de seguridad sobre las\u00a0vacunas de la COVID-19\u00a0y sus posibles reacciones adversas. En dicha actualizaci\u00f3n se informa sobre el descubrimiento de una nueva [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":2875,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_eb_attr":"","hide_page_title":"","footnotes":""},"categories":[7],"tags":[],"class_list":["post-2874","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias"],"_links":{"self":[{"href":"https:\/\/aisperu.org.pe\/cms\/wp-json\/wp\/v2\/posts\/2874","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aisperu.org.pe\/cms\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aisperu.org.pe\/cms\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aisperu.org.pe\/cms\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/aisperu.org.pe\/cms\/wp-json\/wp\/v2\/comments?post=2874"}],"version-history":[{"count":1,"href":"https:\/\/aisperu.org.pe\/cms\/wp-json\/wp\/v2\/posts\/2874\/revisions"}],"predecessor-version":[{"id":5843,"href":"https:\/\/aisperu.org.pe\/cms\/wp-json\/wp\/v2\/posts\/2874\/revisions\/5843"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aisperu.org.pe\/cms\/wp-json\/wp\/v2\/media\/2875"}],"wp:attachment":[{"href":"https:\/\/aisperu.org.pe\/cms\/wp-json\/wp\/v2\/media?parent=2874"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aisperu.org.pe\/cms\/wp-json\/wp\/v2\/categories?post=2874"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aisperu.org.pe\/cms\/wp-json\/wp\/v2\/tags?post=2874"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}